Lycium Anti-Angiogenic Proteoglycan (Retina Pharma)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLycium Anti-Angiogenic Proteoglycan (Retina Pharma)
Drug Alias NameLAP (Retina Pharma)
ClassificationNatural product/ExtractBiologics
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRetina Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRetina Pharma Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A